---
$id: https://graph.org.ai/products/commodity/51143006
$type: Product
source: UNSPSC
code: "51143006"
title: "Choline alfoscerate"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Choline alfoscerate

**UNSPSC Code**: 51143006
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a glycerylphosphorylcholine with the molecular formula C8H20NO6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60M22SGW66, chemically known as ethanaminium, 2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)-n,n,n-trimethyl-, hydroxide, inner salt, (r)- but generally known as choline alfoscerate, which bears US NIH Compound Identifier 71920. European Medicines Agency schedules Choline alfoscerate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06216MIG. World Health Organization schedules choline alfoscerate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule choline alfoscerate under HS 29231000 and SITC 51481. As of Q4 2014, CHOLINE ALFOSCERATE remains the US FDA Preferred Term for this commodity. SMILES: P(=O)(OCC[N](C)(C)C)(OCC(O)CO)O.

